Connection
Peter Kabos to Tetrahydronaphthalenes
This is a "connection" page, showing publications Peter Kabos has written about Tetrahydronaphthalenes.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.710 |
|
|
|
-
Bardia A, Kaklamani V, Wilks S, Weise A, Richards D, Harb W, Osborne C, Wesolowski R, Karuturi M, Conkling P, Bagley RG, Wang Y, Conlan MG, Kabos P. Phase I Study of Elacestrant (RAD1901), a Novel Selective Estrogen Receptor Degrader, in ER-Positive, HER2-Negative Advanced Breast Cancer. J Clin Oncol. 2021 04 20; 39(12):1360-1370.
Score: 0.710